Day ThreeWednesday, 16 August 2023 - EST/EDT (Eastern Daylight, GMT-4)

8:00am - 8:30am

Networking Continental Breakfast

8:30am - 8:45amFree

Co-Chairs’ Review of Day One and Two

8:45am - 9:30amFree

State Transparency Showcase and Tracker – Journey Through New and Unique Requirements Across the Nation

9:30am - 10:15amFree

Drug Pricing Legislation and Price Transparency Reporting

Discuss the current drug pricing transparency environment impacting the industry
Examine key state drug pricing reporting law requirements
Address best practices for monitoring the evolving drug pricing landscape

10:15am - 10:45am

Networking and Refreshment Break

10:45am - 11:30amFree

Stakeholder Spotlight Session—HCP Fireside Chat

Discover best practices for collaboration
Establish mutually beneficial relationships with HCPs
Understand, from first-hand experience, what works well and what can be improved upon to maximize value

11:30am - 12:15pmFree

CCO Luminary Panel— The Top 10 Items on Their Radar and Why They Should be on Yours

12:15pm - 1:15pm

Networking Luncheon

1:15pm - 2:00pmFree

Best Practices for Preparing for a CMS Audit

2:00pm - 3:00pmFree

Spotlight on R&D Transparency

Key topics include:

Global research overview and importance (including CMS requirements for transparency related to research)
Global studies and sites contracted to and run by multiple CROs
Third-party vendor for CRO transparency submissions
Leveraging Clinical Reference Data (CRD) for consistent reporting (MDM)
CRO Reviews – check for completeness and accuracy of transparency data submitted
Research sub-certification – prior to CMS submission
Research database dashboards
CMS dashboard for research sub-certification
Financial transparency dashboard for the CRO Reviews
Research delays
MMSEA adverse event process and reporting requirements

Beth Baker - Senior Manager, Financial Transparency, Global Clinical Operations, Biogen

3:00pm - 3:05pm

Close of Conference